EyePoint Pharmaceuticals GAAP EPS of -$0.99 misses by $0.19, revenue of $0.7M beats by $0.35M
EyePoint, Inc. Common Stock · LABORATORY ANALYTICAL INSTRUMENTS · Now $13.15
-7.5% in 7d after detection
Post-detection moves
1h
—
1d
+0.4%
3d
+4.7%
7d
-7.5%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS